Hurston Waldrep to undergo season-ending elbow surgery

What happened

Braves right-hander Hurston Waldrep will undergo elbow surgery that ends his 2025 season, the club announced Thursday. The procedure closes the book on the rookie's first year in Atlanta.

The announcement did not specify the nature of the elbow injury, the type of surgery planned, or a timetable for Waldrep's return. The club also announced that another pitcher, whose name was included in the announcement, will undergo season-ending elbow surgery, though no further details were provided on that procedure either.

Why it matters

The loss removes a potential rotation piece from Atlanta's depth chart for the remainder of the year, though the Braves have navigated the final weeks of August with a comfortable cushion atop the National League East. The club enters Friday leading the division, and the surgery's impact is felt more in the realm of organizational planning than immediate roster construction.

September roster expansion would have offered a window to audition younger pitchers in lower-leverage situations. That opportunity now shifts to other candidates as the Braves manage their pitching depth through the final month of the regular season.

The timing of the announcement—late August, with rosters about to expand—suggests the club had been monitoring Waldrep and reached a decision point this week. Elbow procedures for pitchers carry widely varying recovery timelines, and the absence of specifics leaves his 2026 outlook uncertain.

Where the club stands

Atlanta sits at 84-58, leading the NL East with a division magic number of 17. The Braves dropped their most recent contest but remain in firm control of their postseason fate as the calendar turns toward September.

The club opens a three-game set against the Colorado Rockies on Friday night at Truist Park. Grant Holmes is slated to start opposite Tomoyuki Sugano. Martín Pérez and Tyler Mahle follow in the weekend series, a rotation that reflects how Atlanta has pieced together its pitching staff down the stretch.

The Braves have built their lead without the luxury of a fully healthy roster. The front office has navigated the summer by mixing veteran acquisitions with internal promotions, a strategy that has kept the club atop the division even as injuries have mounted across the pitching staff.

What we don't know yet

The club did not disclose the specific diagnosis for Waldrep's elbow, the surgical procedure he will undergo, or a recovery timeline. Elbow surgeries for pitchers range widely in severity and prognosis, from minor cleanups that carry a few months of rehab to reconstructive procedures that cost a pitcher more than a calendar year.

Without those details, it is impossible to project when Waldrep might return to a mound or what his development path looks like heading into next season. Whether the injury was acute or the result of accumulated wear is not clear from the club's statement.

The announcement included a second pitcher facing season-ending elbow surgery, but the club provided no additional context on that procedure either. The dual announcement underscores the attrition Atlanta's pitching depth has absorbed throughout the season.

What to watch

The Braves will need to fill the rotation and bullpen depth that Waldrep might have provided in September. The expanded roster allows for additional pitchers to be carried, and Atlanta has candidates in its system who could be summoned for the final month.

The club's magic number of 17 means that any combination of Atlanta wins and second-place losses totaling that figure clinches the division. With 20 games remaining in the regular season, the Braves are positioned to wrap up the East well before the final weekend, which would allow the front office to manage workloads and rest key contributors ahead of October.

Waldrep's recovery will be a storyline to monitor over the winter. The right-hander entered the year as one of the organization's pitching prospects, and the surgery introduces uncertainty into his trajectory. How the Braves handle his rehab and reintegration into game action will shape his outlook for next season.

The nature of the elbow issue and the type of surgery will eventually become clearer, either through additional club statements or through the usual channels of baseball reporting. For now, the Braves have provided only the outcome: Waldrep's season is over, and the focus shifts to recovery and 2026.

The September calculus

Atlanta's comfortable position in the standings affords the club some flexibility in how it manages the final weeks. The Braves can afford to be cautious with pitchers who are nursing minor issues, knowing that the division lead provides a cushion that many contenders lack.

The roster expansion that begins Sunday allows teams to carry up to 28 players, a two-player increase from the August limit. That extra space is typically used to add pitching depth, giving clubs the ability to carry an extra reliever or two and to limit the workload on arms that have logged heavy innings through the summer.

For the Braves, that expansion comes at a moment when the pitching staff has been tested by injuries and attrition. The club has cycled through options all season, and the final month will likely see more of the same as Atlanta balances the competing demands of staying sharp and staying healthy heading into the postseason.

The Rockies series offers a relatively low-stress environment to continue that balancing act. Colorado enters the weekend well out of contention, and the three games at Truist Park represent the kind of matchup that allows a division leader to experiment with its roster without risking much in the standings.

Holmes, Pérez, and Mahle represent the veteran presence that has carried Atlanta's rotation through the summer. None are household names, but all have provided the innings and stability that keep a contender afloat when the marquee arms are unavailable. The Braves have leaned on that tier of pitcher all year, and the final three weeks will ask more of the same.

The organizational view

Waldrep's surgery is a setback for a pitcher who was working his way through the developmental pipeline. The announcement did not include details about where he was pitching or what his role had been, but the timing—late August of his first year in the organization—suggests he was either rehabbing an injury or had been shut down earlier in the summer.

The lack of specifics makes it difficult to assess the long-term impact. Some elbow procedures are routine maintenance, the kind of surgery that has become almost expected for young pitchers in the modern game. Others are more serious, carrying longer recovery timelines and greater uncertainty about a pitcher's future effectiveness.

What is clear is that Waldrep will not pitch again in 2025, and his winter will be spent rehabbing rather than refining his craft. For a young pitcher, that lost development time is meaningful, even if the surgery itself is minor. The Braves will need to account for that gap as they map out his progression for next season.

The club's depth chart will adjust accordingly. Atlanta has built its system to withstand attrition, and the front office has shown a willingness to promote aggressively when the need arises. The final month will reveal which pitchers are next in line and how the organization views its internal options heading into the offseason.

For now, the Braves turn their attention to the Rockies and the business of securing a division title. The pitching staff has absorbed losses all summer; this is simply the latest adjustment in a season that has required constant recalibration. The Braves have managed it well enough to remain the class of the NL East, and the final three weeks will determine whether that depth holds through October.